ClearPoint Neuro (CLPT) Receivables (2011 - 2026)

ClearPoint Neuro has disclosed Receivables across 16 years of filings, most recently posting $9.4 million for Q1 2026.

• Receivables for Q1 2026 came in at $9.4 million, up 151.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.4 million (up 151.59% YoY), and the FY2025 annual result was $6.7 million, up 25.1% from the prior year.
• Receivables came in at $9.4 million for Q1 2026 at ClearPoint Neuro, up from $6.7 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $9.4 million in Q1 2026 to a low of $2.3 million in Q1 2022.
• The 5-year median for Receivables is $3.4 million (2022), against an average of $4.2 million.
• Across the five-year window, Receivables surged 2690.0% in 2022 and slipped 16.4% in 2023, its largest moves.
• ClearPoint Neuro's Receivables stood at $2.7 million in 2022, then rose by 18.57% to $3.2 million in 2023, then surged by 66.77% to $5.4 million in 2024, then gained by 25.1% to $6.7 million in 2025, then soared by 40.87% to $9.4 million in 2026.
• The last three Receivables figures came in at $9.4 million (Q1 2026), $6.7 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.